Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Diabetes Europe 2018

About Conference

With the amalgamation of peerless speakers of Diabetes 2018 ConferenceSeries Ltd is privileged to announce its “27th European Diabetes Congress” which will be held during June 11-12, 2018 Rome, Italy. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming Diabetes congress to witness invaluable scientific discussions and contribute to the future innovations in the field of Diabetes.

Euro Diabetes 2018 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “New recommendations and practical approaches in the field of Diabetes as well as Endocrine disorders” which reflects the innovative progress in Diabetes disease research. The two days conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of Diabetes which include: Physiology & Anatomy of Diabetes, Clinical Research and Case Study : Diabetes, Diabetes prevention and management, Diabetes complication &  disorder in:- children, teens, adolescence, Emerging focus in Diabetes research, Diagnostic approaches of Diabetes, Diabetes & Obesity, Diabetes & Metabolism & action, Diabetes associated diseases, Diabetes medication and therapy, Diabetes market and Business analysis

This Euro Diabetes 2018 Conference invites all the Academic Scientists, Leading Endocrinologists, Surgeons, Primary Health care specialists, Pediatricians, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe where all the aspects of Diabetes Mechanism, Disorders, & Treatment will be discussed under single roof.

One in eight women will develop a Diabetes disorder during her lifetime. And, the number of people suffering from Diabetes disorders continues to rise each year. But the bigger problem is that nearly 60% of these people are completely unaware of their condition let alone how to heal it. Millions of people are suffering trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying Diabetes issues. Reflecting this imperative, ConferenceSeries Ltd believes that professionally-oriented education in Diabetes medicine is essential in the training of clinicians and academicians and organizes Diabetes conference in Lisbon, Portugal this year which will provide the future leadership in this key area for global health. ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

In support of improving patient care, this activity has been planned and implemented by Conference Series, Ltd and Center for Education Development (CED). CED is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Center for Education Development designates the live format for this educational activity for AMA PRA Category 1 Credits™ and ANCC credit. Participants should only claim credit commensurate with the extent of their participation in the activity. Full accreditation information including disclosures, credit hours available and faculty information will be provided in the attendee handout onsite.

Why to attend?

With members from around the world focused on learning about Diabetes Disorders and its advances in making a better health; this is your best opportunity to reach the largest assemblage of participants from the Diabetes community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Diabetes Disorders are hallmarks of this conference.

Target Audience:

Ø  Academic researcher

Ø  Endocrinologists

Ø  Dibetologists

Ø  Data management companies

Ø  Medical colleges

Ø  Training institute

Ø  Diabetes Societies & Association

Ø  Medical & Pharmacy Companies

Ø  Software development companies

Ø  Business entrepreneurs

Ø  Manufacture medical devices & companies

Market Analysis

27th European Diabetes Congress” is going to be held during June 11-12, 2018 Rome, Italy. The Conference will be organized around the theme “New recommendations and practical approaches in the field of Diabetes as well as Endocrine disorders” highlighting the latest and exciting innovations in Diabetes Disease& Treatment. Diabetes 2018 Conference invites all Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes conference under a single roof where networking and global partnering happens for the acceleration of future research.

Today’s Market Study of Diabetes in USA | Europe | Middle East | Asia Pacific

Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.

USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000

Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1.

Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.

For more details please visit- http://www.diabetesexpo.com/europe/

Conference Highlights:

  • Diabetes Melitus
  • Diabetes Chronic Complication
  • Biomarkers for Diabetes
  • Diabetes Research
  • Treatment Of Diabetes
  • Insulin Medication
  • Type 2 diabetes & Obesity
  • Metabolic Syndrome
  • Biology of Diabetes
  • Transplantation/ Immunology
  • Genetics of Diabetes
  • Diabetes Medication & Therapy

Importance & Scope

Millions of people are suffering and also trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying Diabetes issues.

Number of people suffering from Diabetes disorders & continues to rise each year. As reported by the World Health Organization (WHO), on an average 1 out of every 13 people more specifically 20 million to 750 million cases are diagnosed globally with Diabetes diseases each year. There are more than 250 million cases with Obesity globally. Around 60% of the populations effected with Diabetes disorder are uncaring of the situation. Male & Female population is 5-6 times more likely to develop a Diabetes disorder.

Many International Conferences meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as obesity conferences, weight loss conferences, Endocrine Conferences etc.

ConferenceSeries Ltd Cordially invites all the Academic Scientists, Leading Endocrinologists, Diabetologists, Pediatricians, Surgeons, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes Conference, where all the aspects of Diabetes Disorders and Treatment will be discussed under single roof. Diabetes 2018 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes 2018 is an international platform for presenting research about Diabetes significance, Disorders & Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society.

Why Italy?

The prevalence of diabetes as well as glucose intolerance is greater in men and in the regions of the Center and South of Italy. The prevalence of diabetes has doubled in Italy over the past decade and now affects about 3 million people. In Italy, the prevalence of diabetes is 6.6% among people over 20 years old, The Italian Ministry of Health estimates that the number of total undiagnosed cases of diabetes is approximately 2 million. By 2013, the number of cases of both type 1 and type 2 are expected to rise to about 2.7 million and 4 million, respectively. Current diabetes incidence ranges from 4 to 10 new cases per 100,000 inhabitants annually throughout most of the country, but is as high as 35 new cases per 100,000 in Sardinia. Approximately 15,000 new cases of type 1 diabetes and 185,000 new cases of type 2 diabetes are diagnosed nationwide each year, resulting in a and a type 1:type 2 ratio of 1:9. One recent study by the Associazione Medici Diabetologi (AMD, the Italian Association of Diabetes Doctors) found that the number of cases of both type 1 and type 2 diabetes is increasing at about 1% and 7-10% per year, likely due in part to improved screening measures and an increase in obesity and sedentary lifestyles. Reflecting this imperative Euro Diabetes 2018 aims to educate pediatricians and achieve the goal of reducing infant mortality rate.

Why to attend ???

Medical doctors, patients and health care providers consider the prevention of Diabetes diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey. Realizing this imperative, Conference Series LLC is set to organize 27th European Diabetes Congress for the upcoming year with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered.

Diabetes-2018 conference is comprised of 11 tracks designed to offer sessions including anatomy & physiology of diabetes, acute & chronic complication, Bio-marker: diagnostic tools for diabetes, emerging focus on diabetes research,   Advanced Technologies For The Treatment Of Diabetes, Diabetes & Insulin Medication, Integrated Physiology/Obesity, Diabetes & Metabolic Syndrome, Computational Biology Of Diabetes, Transplantation/immunology, Diabetes Medication & Therapy.

Members Associated with Diabetes Research

The American Diabetes Association (ADA) serves as the professional for all the leading researchers and clinicians and also for the people in the field of Diabetes, and provides a rich resource for the public and patients with Diabetes disease and Obesity. 1700 members from 43 different countries, working together in the organization of Researchers , Clinicians, Surgeons,  and other Healthcare professionals, to advance the care and treatment of patients with Diabetes disease. Also to inspire, educate, apprise and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the world to professionally avoid and combat the lethal disease.

Major Diabetes Association in Portugal

Ø  Diabetic Association of Portugal.

Major Diabetes Association in Europe

Ø  European association for the study of diabetes

Ø   European diabetes foundation

Ø   Diabetes Association Switzerland

Ø  Spanish Diabetes Society (Spain)

Ø   Swedish Diabetes Association

Major Diabetes Association in USA

Ø  American Diabetes Association

Ø  American Association of Clinical Endocrinologists

Ø   Centre for Disease Control: Division of Diabetes Translation

Ø  Diabetes Advocacy Alliance

Ø    Diabetes Hands Foundation

Ø  Juvenile Diabetes Foundation International

Ø  National Kidney Foundation

Ø  National Institute of Diabetes and Digestive and Kidney Diseases

Major Diabetes Association around the Globe

Ø  Diabetes Indian Association

Ø   Canadian Diabetes Association

Ø  International Diabetes Federation

Ø  Diabetes Australia

Ø  Austrian Diabetes Association.

Ø  Diabetes South Africa

Ø  Asia diabetes foundation

Ø  Asian association for the study of diabetes

Ø  Korean Diabetes Association

Target Audience:-

Euro Diabetes 2018 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of Thyroid under a single roof where networking and global partnering happens for the acceleration of future research. Following are the areas for targeting the audience percentage wise:

Scientists      60%

Academia    40%

Doctors       10%

Market Analysis on Diabetes

Diabetes industry guides to the 11 largest pharmaceutical and diagnostic companies producing diabetes related products or those involved with diabetes research. Diabetes is a major problem in the UK, and as such a large healthcare and treatment industry has built up around it .Diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market.

Global Prevelance of Diabetes

One in 10 people globally will have diabetes by 2035, according to a concerning new report. To highlight World Diabetes Day which takes place each year on Nov. 14, the International Diabetes Federation (IDF) released its sixth edition of the Diabetes Atlas. The report estimates how many adults between the ages of 20 to 79 will be affected by the disease in the future. By the end of this year, the IDF estimates that 382 million people will have diabetes around the world. By 2035, that number will skyrocket to 592 million. For comparison, about 285 million people had the disease just four years ago. Eighty percent of people with the disease live in low- and middle-income countries, and most of them are between 40 and 59 years old. The organization also said that one person dies from diabetes every six seconds, or about 5.1 million deaths annually.

Past Conference Report

Euro Diabetes 2017

The 27th European Diabetes Congress (Euro Diabetes 2017) convoked by Conference Series LLC during July 17-18, 2017 was successfully held at Embassy suites Lisbon, Portugal with a theme “Diabetes Explosion: Developments and Changing Life of Diabetes World” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

Thanks to all our momentous speakers, conference attendees who contributed towards the successful run of the conference.

Euro Diabetes 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Endocrinology, Diabetes, Pediatrics, and Surgery.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Diabetes Melitus
  • Diabetes Chronic Complication
  • Biomarkers for Diabetes
  • Diabetes Research
  • Treatment Of Diabetes
  • Insulin Medication
  • Type 2 diabetes & Obesity
  • Metabolic Syndrome
  • Biology of Diabetes
  • Transplantation/ Immunology
  • Genetics of Diabetes
  • Diabetes Medication & Therapy

Euro Diabetes 2017 Organizing Committee would like to thank the Moderators of the conference, Ualikhanova A, RUDN University, Russia and Sherry Elisha Mata, Cairo University, Egypt who has contributed a lot for the smooth functioning of this event.

Euro Diabetes 2017 extends its warm gratitude to all the Honourable Guest and Keynote Speakers of the event:

  • Dr. Palayakotai Raghavan, CEO of Nanorx INC; USA.
  • Dr. Arturo Solis Herrera; Director and Founder of Human Photosynthesis® Research Center, Mexico
  • Dr. Nandakumaran Moorkath, professor at University of Kuwait, Kuwait.
  • Dr. Irina Kurnikova, Professor of Medicine in RUDN University, Russia.

Conference Series LLC is privileged to felicitate Euro Diabetes 2017 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. Conference Series LLC would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Diabetes.

With the valuable feedback received from the participants of Euro Diabetes 2017, Conference Series LLC is glad to announce the commencement of “27th European Diabetes Congress during June 11-12, 2018 at Rome, Italy. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing diabetes and its concomitant risk factors.


Past Reports  Proceedings  Gallery  

Past Conference Report

Supported By

Journal of Diabetes & Metabolism Pancreatic Disorders & Therapy Journal of Steroids & Hormonal Science

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by